ReNu® Advanced Amniotic Allograft by Organogenesis
The Graivier Center is offering a groundbreaking treatment to support healing of soft tissues, particularly in degenerative conditions such as osteoarthritis (OA) pain and joint and tendon injuries.
This treatment is called ReNu® Advanced Amniotic Allograft by Organogenesis. ReNu® is a cryopreserved, bioactive amniotic suspension allograft, derived from human amnion and amniotic fluid. The human amniotic tissues in ReNu® contain cellular, growth factor, and extracellular matrix components, and are naturally rich in anti-inflammatory factors.
ReNu® can be used to promote tissue regeneration and healing of diseased or injured cells and organs.
ReNu® is a single-injection, nonsteroidal prescription treatment that can be done in an office setting with little to no discomfort. Relief may last up to one year and frees you from having to take oral treatments such as NSAIDs or steroid injections.
ReNu® will improve healing of OA or other orthopedic conditions or injuries, while reducing joint pain, scarring, and inflammation of and around the site of the pain. Improvement may be seen anywhere from 2-6 weeks following treatments. Once improvement in pain is experienced you may resume a modified exercise routine as directed by your physician.
This advanced, modern treatment is a part of the emerging, dynamic approach of regenerative medicine. Regenerative medicine is a multidisciplinary field involving biology, medicine and engineering. It delivers living tissue to stimulate the body’s inherent ability to repair and regenerate when it will not heal on its own. Regenerative medicine may help heal broken bones, severe burns and chronic wounds.
Call The Graivier Center to schedule a consultation today.